Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Epidemiology

Pediatric Cancer

What Causes Cancer?

Cancer Research

What Role do Biobanks Play in Cancer Research?

Secondary Lung Cancer

Why are Cancer Cell Lines Useful?

Targeted Cancer Therapies

Using Biomarkers to Detect Cancer

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Caring for a Loved One with Cancer

See more featured articles »

What is Merkel Cell Carcinoma?

Insight into Cancer Vaccines

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cutaneous Manifestations of Internal Malignancy

Assay for Monitoring and Treating Malignant Brain Tumors

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

What is Immunochemotherapy?

Microfluidic cancer treatment screen combined with flow cytometry

Hot vs Cold: the differences between tumor types

Cancer Management

Cancer Pain Management

TARDIS: The Improved Method of Detecting Breast Cancer

Overview of Cell Viability and Cytotoxicity

What is Tumorigenesis?

Myc Mutations and Cancer

Living with Cancer Pain

What is Cancer of Unknown Primary?

Transforming Cancer Care through Genomic Testing

What is Cancer?

Insights into Oncofertility

The Effects of Cancer on Family Life

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

The Biochemistry of Breast Cancer Screening

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Pain

Is Cancer a Metabolic Disorder?

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Prognosis

British Pioneers in Cancer Biology

Investigating the Molecular Mechanisms of Cancer

Secondary Brain Cancer

CDK9 and Cancer

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

The Cancer Cell Surface Proteome as a Therapeutic Target

Acidosis and Tumor Progression

Cancer Symptoms

Cancer Glossary

What is the Tumor Microenvironment?

Cancer History

Exploiting Enzymes in Cancer Diagnosis and Therapy

Effects of Social and Economic Deprivation on Cancer Mortality

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Classification

Hypoxia Markers and Their Importance

Cancer Pathophysiology

Cancer Prevention: Lowering your Risk

Cancer Diagnosis

Latest Cancer News and Research

LEF1 and niche-derived factors regulate T cell stemness across chronic diseases

T cells are an elite fighting force of the immune system, seeking out and destroying diseased cells. But in a prolonged campaign against a chronic condition - like a viral infection, or cancer - the body needs a steady supply of these killer troops.

1 Jul 2026

Fatty liver disease fuels aggressive metastatic colorectal cancer spread

Researchers at VIB and KU Leuven, with international partners, have uncovered how fatty liver disease can fuel the most aggressive form of metastatic colorectal cancer.

1 Jul 2026

German study identifies therapeutic Achilles' heel for advanced colorectal cancer

A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer.

1 Jul 2026

CAR-T cell therapy shows potential to eliminate aggressive glioblastoma

A study led by a researcher based at King's College London and McMaster University in Canada reveals how CAR-T cell therapy, a treatment that engineers a patient's own immune cells to recognize and attack cancer, could be used to treat glioblastoma.

1 Jul 2026

Advanced imaging technology unlocks exosome potential for disease diagnosis

Tiny particles released by most human cells may be promising targets for diagnosis and treatment of an array of diseases from cancer to Alzheimer's, but scientists have struggled to see them and study them in detail.

1 Jul 2026

New bacterial enzyme blueprint could accelerate cancer treatment development

A team of researchers at the University of Warwick and Monash University has solved a puzzle that's stumped drug developers for decades: how bacteria naturally create multiple versions of powerful cancer therapies.

1 Jul 2026

Alexandre Detappe wins ERC grant for nanomedicine-based cancer immunotherapy

The ERC (European Research Council) Proof of Concept grant awarded to Alexandre Detappe (Gustave Roussy/Institut Strauss/Université Paris-Saclay/Inserm) will fund the Nano-BITE project, which aims to improve the ability of the immune system to fight solid tumors through nanomedicine.

1 Jul 2026

Cancer's biggest treatment challenge may be getting solved 250 miles above Earth

For more than two decades, precision oncology has been promoted as the future of cancer treatment, matching therapies to the unique biology of a patient's tumor.

1 Jul 2026

New AI framework outperforms conventional biomarkers in predicting cancer survival

Digestive system cancers, including hepatobiliary and gastrointestinal malignancies, remain a major global oncological burden. Although immune checkpoint inhibitors have changed the treatment landscape for some patients, their overall efficacy remains limited, with only about 15% to 30% of patients achieving durable clinical benefit.

1 Jul 2026

Dual-target CAR-T therapy shows promise against aggressive brain tumors

Researchers at McMaster University have developed a new cancer immunotherapy strategy that can simultaneously attack deadly brain tumors and the immune cells that help them grow.

1 Jul 2026

Monoclonal antibody shows promise for treating acute respiratory distress syndrome

Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or ARDS.

30 Jun 2026

Study links DNA methylation to aggressive prostate cancer behavior

The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million American men, with another 330,000 men expected to be diagnosed with the condition this year alone.

30 Jun 2026

Review highlights strong safety and effectiveness of mRNA vaccines

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly effective at preventing infectious diseases, including COVID-19.

30 Jun 2026

Blood protein clocks flag higher risks of death and chronic disease

Proteomic age clocks applied to two European cohorts linked faster biological aging with smoking, alcohol use, physical inactivity, all-cause mortality, cardiovascular disease, dementia, and several cancers. The Global proteomic clock predicted mortality as well as established lifestyle risk factors, while organ-specific clocks showed stronger links with related cancers of the kidney, lung, and stomach.

30 Jun 2026

Researchers use AI to predict rare cancer immunotherapy responses

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based analysis of tumor biopsies can predict responses to immunotherapy in a study of patients with rare cancers, published in the Journal for ImmunoTherapy of Cancer.

30 Jun 2026